|
|
Article: Antares Pharma, Inc. and GeneMedix plc Announce Their Intent to Form a Collaboration to Link GeneMedix's Biopharmaceutical Products With Antares Pharma's Device Technology.
- Article from:
- PR Newswire
- Article date:
- March 25, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antares Pharma, Inc. and GeneMedix plc (LONDON: GMX) today announced their intention to form a collaboration through which Antares Pharma's current and future injection devices would be used to support GeneMedix's introduction of generic biopharmaceuticals in certain territories. Specifics of the biopharmaceutical products, territories and future financial terms of the collaboration were not disclosed.
Roger G. Harrison, Chief Executive Officer and President of Antares Pharma, said, "We are delighted with this collaboration. GeneMedix currently has an impressive portfolio of biopharmaceuticals in development and one product already on the Asian market. We ...